Annual report pursuant to Section 13 and 15(d)

Organization, Basis of Presentation and Consolidation, and Significant Accounting Policies - Additional Information (Details)

v3.22.4
Organization, Basis of Presentation and Consolidation, and Significant Accounting Policies - Additional Information (Details)
 3 Months Ended 12 Months Ended
Nov. 30, 2021
shares
Nov. 02, 2021
USD ($)
$ / shares
shares
Oct. 18, 2021
Dec. 31, 2022
USD ($)
Dec. 31, 2022
USD ($)
segment
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Subsidiary, Sale of Stock [Line Items]              
Reverse stock split ratio     0.06262000        
Payment of initial public offering issuance costs         $ 0 $ 5,543,000 $ 0
Options exercised (in shares) | shares (2,424)            
Tax receivable agreements, term         12 years    
Tax receivable agreements, percentage of benefits payable to shareholders       0.85 0.85    
Income tax (benefit) expense       $ 100,000 $ (79,052,000) 2,686,000 3,938,000
Tax receivable agreement liability       210,543,000 $ 210,543,000 210,639,000  
Number of reportable segments | segment         1    
Restricted cash held in escrow       41,128,000 $ 41,128,000 40,662,000  
Restricted cash and cash equivalents           3,900,000  
Deferred offering costs       $ 5,500,000 5,500,000    
Goodwill, impairment loss         $ 0 0 $ 0
Capitalized contract cost, amortization period       7 years 7 years    
CARES retention credits           3,900,000  
Former Investor              
Subsidiary, Sale of Stock [Line Items]              
Restricted cash held in escrow       $ 1,100,000 $ 1,100,000 $ 1,100,000  
Minimum              
Subsidiary, Sale of Stock [Line Items]              
Lessee, operating lease, term of contract       1 year 1 year    
Maximum              
Subsidiary, Sale of Stock [Line Items]              
Lessee, operating lease, term of contract       12 years 12 years    
IPO              
Subsidiary, Sale of Stock [Line Items]              
Sale of stock, number of shares issued (in shares) | shares   22,222,222          
Sale of stock, price (in dollars per share) | $ / shares   $ 19.00          
Sale of stock, consideration received   $ 393,500,000          
Payment of initial public offering issuance costs   23,200,000          
Recognition of liability under tax receivable agreement   $ 5,500,000